FDA Issues Strattera Public Health Advisory On Suicidal Thinking
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory alerts physicians to the risk of suicidal thinking in children and adolescents related to use of Eli Lilly's ADHD therapy atomoxetine.